The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Enrichment of the germline NLRC5Pro191Leu variant in patients with immune checkpoint inhibitor–induced hepatitis.

Shira  Gabizon Peretz

Leadership - LipoMedix (I)

Stock and Other Ownership Interests  - Various pharmaceutical companies (I)

Consulting or Advisory Role - LipoMedix (I)

Research Funding - Merck (I)

Noam  Savion Gaiger

No Relationships to Disclose

Jacqueline  Mann

Consulting or Advisory Role - Neion Bio

Harriet  Kluger

Consulting or Advisory Role - Genmab; GI Reviewers; Immunocore; Invox; Iovance Biotherapeutics; Replimune; Teva; TuHura; Werewolf Pharma

Research Funding - Apexigen (Inst); Asherbio Therapeutics (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)

Travel, Accommodations, Expenses - Apexigen